Innate Pharma (IPHA) Enterprise Value (2017 - 2025)
Innate Pharma posted quarterly Enterprise Value of -$39.9 million for Q4 2025, up 53.73% year-on-year from -$26.0 million in Q4 2024, and up 51.48% on a QoQ basis from -$82.3 million in Q2 2025.
Innate Pharma (IPHA) has 9 years of Enterprise Value data on file, last reported at -$39.9 million in Q4 2025.
- For the quarter ending Q4 2025, Enterprise Value rose 53.73% year-over-year to -$39.9 million; the trailing twelve-month figure through Dec 2025 stood at -$39.9 million (up 53.73% YoY), and the FY2025 full-year result was -$39.9 million, up 53.73% from the prior year.
- Enterprise Value for Q4 2025 stood at -$39.9 million, up from -$82.3 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$39.9 million in Q4 2025 and bottomed at -$183.2 million in Q2 2021.
- The 5-year median for Enterprise Value is -$101.5 million (2022), against an average of -$107.5 million.
- The widest annual swing landed in 2021, when Enterprise Value soared 99.88%; it then gained 3.92% in 2023.
- A 5-year view of Enterprise Value shows it stood at -$137.1 million in 2021, then grew by 24.47% to -$103.5 million in 2022, then advanced by 3.92% to -$99.5 million in 2023, then advanced by 13.24% to -$86.3 million in 2024, then jumped by 53.73% to -$39.9 million in 2025.
- The last three Enterprise Value figures came in at -$39.9 million (Q4 2025), -$82.3 million (Q2 2025), and -$86.3 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | -901.90 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | -8.75 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | -18.44 Mn |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Innate Pharma | 199.64 Mn | 199.64 Mn | - | -39.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -39.94 Mn |
| Jun 30, 2025 | -82.31 Mn |
| Dec 31, 2024 | -86.31 Mn |
| Jun 30, 2024 | -99.52 Mn |
| Dec 31, 2023 | -99.48 Mn |
| Jun 30, 2023 | -110.74 Mn |
| Dec 31, 2022 | -103.54 Mn |
| Jun 30, 2022 | -132.48 Mn |
| Dec 31, 2021 | -137.09 Mn |
| Jun 30, 2021 | -183.21 Mn |
| Dec 31, 2020 | -180.80 Mn |
| Jun 30, 2020 | -147.74 Bn |
| Dec 31, 2019 | -242.26 Mn |
| Jun 30, 2019 | -171.15 Mn |
| Dec 31, 2018 | -191.22 Mn |
| Dec 31, 2017 | -136.71 Mn |